Macitentan Responsiveness Supports the Validity of a Murine Model of Pulmonary Hypertension in Scleroderma Associated with Altered Tgfbeta/BMPR2 Signalling
EC Derrett-Smith, CP Denton(The Royal Free Hospital), A Holmes, Yasmina Bauer, A Gilbane, Sarah L. Trinder(Queen Mary University of London), Marc Iglarz, Bérengère Renault, Dietmar Abraham(Medical University of Vienna), Vincent Sobanski(Inserm)
UCL Discovery (University College London)
October 1, 2015
Cited by 0
Related Papers
Prevalence and outcome in systemic sclerosis associated pulmonary arterial hypertension: application of a registry approach
|Annals of the Rheumatic Diseases|2003|769
Bosentan treatment of digital ulcers related to systemic sclerosis: results from the RAPIDS-2 randomised, double-blind, placebo-controlled trial
|Annals of the Rheumatic Diseases|2010|503
Survival and Prognostic Factors in Systemic Sclerosis–Associated Pulmonary Hypertension: A Systematic Review and Meta‐Analysis
|Arthritis & Rheumatism|2013|269
Raf-1-associated Protein Phosphatase 2A as a Positive Regulator of Kinase Activation
|Journal of Biological Chemistry|2000|219